APA (7th ed.) Citation

Daher, A., Müller, T., Spiesshoefer, J., Dreher, M., & Panse, J. (2021). Successful treatment of prolonged COVID-19 with Bamlanivimab in a patient with severe B-Cell aplasia due to treatment with an anti-CD20 monoclonal antibody: A case report. Elsevier.

Chicago Style (17th ed.) Citation

Daher, Ayham, Tobias Müller, Jens Spiesshoefer, Michael Dreher, and Jens Panse. Successful Treatment of Prolonged COVID-19 with Bamlanivimab in a Patient with Severe B-Cell Aplasia Due to Treatment with an Anti-CD20 Monoclonal Antibody: A Case Report. Elsevier, 2021.

MLA (8th ed.) Citation

Daher, Ayham, et al. Successful Treatment of Prolonged COVID-19 with Bamlanivimab in a Patient with Severe B-Cell Aplasia Due to Treatment with an Anti-CD20 Monoclonal Antibody: A Case Report. Elsevier, 2021.